Drugs for Neglected Diseases initiative - DNDi
Sandra Rembry is an experienced clinical project leader with a robust background in managing clinical trials across various organizations. Currently serving as a Clinical Project Leader at the Drugs for Neglected Diseases initiative since June 2015, Sandra has previously held the role of Clinical Operations Manager at NovImmune and Senior Clinical Trial Manager at Merck Serono. Sandra's expertise encompasses coordination and management of international phase II and III studies during tenure at Servier. Educational qualifications include a Master in Industrial and Biomedical Pharmacy and a Doctorate in Pharmacy from Université Paris Cité, along with additional advanced degrees in Biological and Medical Sciences and training in clinical trials.
This person is not in any teams
This person is not in any offices